A Study of Avelumab In Combination With Axitinib in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumor After Failure of Standard Therapy (AXAGIST)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04258956 |
|
Recruitment Status : Unknown
Verified February 2020 by Maria Sklodowska-Curie National Research Institute of Oncology.
Recruitment status was: Recruiting
First Posted : February 6, 2020
Last Update Posted : February 6, 2020
|
Sponsor:
Maria Sklodowska-Curie National Research Institute of Oncology
Information provided by (Responsible Party):
Maria Sklodowska-Curie National Research Institute of Oncology
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Unknown |
|---|---|
| Estimated Primary Completion Date : | April 30, 2021 |
| Estimated Study Completion Date : | April 30, 2023 |